IL101241A
(en)
*
|
1992-03-16 |
1997-11-20 |
Yissum Res Dev Co |
Pharmaceutical or cosmetic composition comprising stabilized oil-in-water type emulsion as carrier
|
DE4244122C1
(de)
*
|
1992-12-24 |
1994-06-01 |
Sanol Arznei Schwarz Gmbh |
Lyophilisierte, wirkstoffhaltige Emulsion zur intravenösen Applikation
|
WO1994023749A1
(en)
*
|
1993-04-19 |
1994-10-27 |
Institute For Advanced Skin Research Inc. |
Microemulsion preparation containing difficultly absorbable substance
|
ES2070076B1
(es)
*
|
1993-04-20 |
1996-04-16 |
Cusi Lab |
Metodo para aumentar la estabilidad de las nanocapsulas durante su almacenamiento.
|
US5576016A
(en)
*
|
1993-05-18 |
1996-11-19 |
Pharmos Corporation |
Solid fat nanoemulsions as drug delivery vehicles
|
US20020099067A1
(en)
*
|
1993-07-08 |
2002-07-25 |
Ulrich Posanski |
Pharmaceutical compositions for sparingly soluble therapeutic agents
|
IL106578A
(en)
*
|
1993-08-03 |
2000-08-13 |
Yissum Res Dev Co |
Pharmaceutical compositions for drug targeting
|
FR2709666B1
(fr)
*
|
1993-09-07 |
1995-10-13 |
Oreal |
Composition cosmétique ou dermatologique constituée d'une émulsion huile dans eau à base de globules huileux pourvus d'un enrobage cristal liquide lamellaire.
|
US5961970A
(en)
*
|
1993-10-29 |
1999-10-05 |
Pharmos Corporation |
Submicron emulsions as vaccine adjuvants
|
US5672358A
(en)
*
|
1994-06-21 |
1997-09-30 |
Ascent Pharmaceuticals, Inc. |
Controlled release aqueous emulsion
|
JPH0827018A
(ja)
*
|
1994-07-22 |
1996-01-30 |
Sanwa Kagaku Kenkyusho Co Ltd |
生理活性ペプチド又は蛋白質を含有する薬剤組成物
|
PT854729E
(pt)
*
|
1995-09-18 |
2004-08-31 |
Us Army Med Res Mat Com Usamrm |
Metodos melhorados para a producao de vacinas de subunidade multivalentes de proteossomas complexados nao covalentemente
|
JPH11513698A
(ja)
*
|
1995-10-25 |
1999-11-24 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
神経保護物質およびパーフルオロケミカルの注射剤
|
US5980945A
(en)
*
|
1996-01-16 |
1999-11-09 |
Societe De Conseils De Recherches Et D'applications Scientifique S.A. |
Sustained release drug formulations
|
ES2118033B1
(es)
*
|
1996-02-16 |
1999-07-01 |
Bial Ind Farmaceutica S A |
Formulacion farmaceutica antiinflamatoria.
|
SE9602280D0
(sv)
*
|
1996-06-10 |
1996-06-10 |
Pharmatrix Ab |
Immunstimulerande lipidformulering
|
AU727447B2
(en)
*
|
1996-07-03 |
2000-12-14 |
University Of Pittsburgh |
Emulsion formulations for hydrophilic active agents
|
IL128632A
(en)
*
|
1996-08-22 |
2003-03-12 |
Rtp Pharma Corp |
Compositions comprising microparticles of water-insoluble substances and method for preparing same
|
US7255877B2
(en)
*
|
1996-08-22 |
2007-08-14 |
Jagotec Ag |
Fenofibrate microparticles
|
US6465016B2
(en)
*
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
SE9603667D0
(sv)
*
|
1996-10-08 |
1996-10-08 |
Astra Ab |
Pharmaceutical compositions
|
US6071904A
(en)
*
|
1996-12-11 |
2000-06-06 |
Alcon Laboratories, Inc. |
Process for manufacturing ophthalmic suspensions
|
US7060277B2
(en)
*
|
1996-12-30 |
2006-06-13 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Broad spectrum antagonists and vaccines directed against pyrogenic exotoxins
|
US6537561B1
(en)
*
|
1997-02-27 |
2003-03-25 |
Nippon Shinyaku Co., Ltd. |
Fat emulsion for oral administration
|
US6143276A
(en)
*
|
1997-03-21 |
2000-11-07 |
Imarx Pharmaceutical Corp. |
Methods for delivering bioactive agents to regions of elevated temperatures
|
US5980912A
(en)
*
|
1997-03-25 |
1999-11-09 |
Zonagen, Inc. |
Chitosan induced immunopotentiation
|
SE9702776D0
(sv)
*
|
1997-07-22 |
1997-07-22 |
Pharmacia & Upjohn Ab |
Method of preparing pharmaceutical compositions
|
US6306433B1
(en)
|
1997-08-12 |
2001-10-23 |
Pharmacia Ab |
Method of preparing pharmaceutical compositions
|
IL122084A
(en)
*
|
1997-10-31 |
1999-09-22 |
Lurident Ltd |
Formulation for personal care with mucoadhesive properties
|
US6270464B1
(en)
|
1998-06-22 |
2001-08-07 |
Artemis Medical, Inc. |
Biopsy localization method and device
|
GB9726916D0
(en)
*
|
1997-12-19 |
1998-02-18 |
Danbiosyst Uk |
Nasal formulation
|
US6221378B1
(en)
|
1998-02-10 |
2001-04-24 |
Generex Pharmaceuticals Incorporated |
Mixed micellar delivery system and method of preparation
|
US6017545A
(en)
*
|
1998-02-10 |
2000-01-25 |
Modi; Pankaj |
Mixed micellar delivery system and method of preparation
|
US7070799B1
(en)
*
|
1998-02-10 |
2006-07-04 |
Generex Pharmaceuticals, Inc. |
Method for administering insulin to the buccal region
|
KR100492098B1
(ko)
|
1998-03-09 |
2005-06-01 |
다케다 야쿠힌 고교 가부시키가이샤 |
시클로알켄 유도체, 그의 제조 방법 및 용도
|
DE19819273A1
(de)
*
|
1998-04-30 |
1999-11-11 |
Pharmatec International S Giul |
Pharmazeutische Ciclosporin-Formulierung mit verbesserten biopharmazeutischen Eigenschaften, erhöhter physikalischer Qualität und Stabilität sowie Verfahren zur Herstellung
|
DK1075276T3
(da)
*
|
1998-05-07 |
2008-02-11 |
Corixa Corp |
Adjuvanssammensætning og fremgangsmåder til dens anvendelse
|
TWI241915B
(en)
|
1998-05-11 |
2005-10-21 |
Ciba Sc Holding Ag |
A method of preparing a pharmaceutical end formulation using a nanodispersion
|
DK1079808T3
(da)
|
1998-05-29 |
2004-06-07 |
Skyepharma Canada Inc |
Præparater med termisk beskyttede mikropartikler og fremgangsmåde til slutdampsterilisering deraf
|
AU5207799A
(en)
*
|
1998-07-02 |
2000-01-24 |
Genzyme Corporation |
Transgene expression in polarized cells
|
DE19830375A1
(de)
*
|
1998-07-08 |
2000-01-13 |
K D Pharma Bexbach Gmbh |
Mikroverkapselte ungesättigte Fettsäure oder Fettsäureverbindung oder Mischung aus Fettsäuren und/oder Fettsäureverbindungen
|
JP2007262088A
(ja)
*
|
1998-08-31 |
2007-10-11 |
Nipro Corp |
栄養輸液製剤
|
EP0988857B8
(en)
*
|
1998-08-31 |
2006-05-03 |
Nipro Corporation |
Nutrient infusion preparation
|
EP1121088B1
(de)
*
|
1998-10-14 |
2002-12-18 |
Cognis Deutschland GmbH & Co. KG |
Verwendung von nanoskaligen sterolen und sterolestern
|
US7939105B2
(en)
|
1998-11-20 |
2011-05-10 |
Jagotec Ag |
Process for preparing a rapidly dispersing solid drug dosage form
|
FR2787326B1
(fr)
*
|
1998-12-17 |
2001-01-26 |
Oreal |
Nanoemulsion a base d'esters gras de glycerol, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
PT1154759E
(pt)
|
1998-12-30 |
2008-11-20 |
Dexcel Ltd |
Concentrado dispersível para administração de ciclosporina
|
US7767216B2
(en)
*
|
1999-04-28 |
2010-08-03 |
The Regents Of The University Of Michigan |
Antimicrobial compositions and methods of use
|
US7655252B2
(en)
*
|
1999-04-28 |
2010-02-02 |
The Regents Of The University Of Michigan |
Antimicrobial nanoemulsion compositions and methods
|
US8236335B2
(en)
*
|
1999-04-28 |
2012-08-07 |
The Regents Of The University Of Michigan |
Antimicrobial nanoemulsion compositions and methods
|
BR0010354A
(pt)
*
|
1999-05-07 |
2002-03-05 |
Pharmasol Gmbh |
Partìculas de lipìdeo à base em misturas de lipìdeos lìquidos e sólidos e método para a sua produção
|
EP1189597A4
(en)
*
|
1999-06-04 |
2008-06-18 |
Pacira Pharmaceuticals Inc |
COMPOSITIONS USING AN OIL CORE FOR DELAYED RELEASE HYDROPHOLE MEDICAMENTS
|
US7732404B2
(en)
|
1999-12-30 |
2010-06-08 |
Dexcel Ltd |
Pro-nanodispersion for the delivery of cyclosporin
|
US6541025B1
(en)
|
1999-12-30 |
2003-04-01 |
Shear/Kershman Laboratories, Inc. |
Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals
|
US7919113B2
(en)
*
|
1999-12-30 |
2011-04-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Dispersible concentrate lipospheres for delivery of active agents
|
US6514523B1
(en)
|
2000-02-14 |
2003-02-04 |
Ottawa Heart Institute Research Corporation |
Carrier particles for drug delivery and process for preparation
|
AU3847801A
(en)
*
|
2000-02-15 |
2001-08-27 |
Intellivax International Inc |
Proteosome influenza vaccine
|
FR2805761B1
(fr)
*
|
2000-03-02 |
2002-08-30 |
Mainelab |
Nanocapsules lipidiques, procede de preparation et utilisation comme medicament
|
WO2001066700A1
(en)
*
|
2000-03-09 |
2001-09-13 |
Emory University |
Transcutaneous immunization for large particulate antigens
|
US6861060B1
(en)
|
2000-04-21 |
2005-03-01 |
Elena Luriya |
Personal care formulations
|
DE10027948A1
(de)
*
|
2000-06-08 |
2001-12-20 |
Henkel Kgaa |
Verfahren zur Herstellung von Nanopartikel-Suspensionen
|
US8512718B2
(en)
|
2000-07-03 |
2013-08-20 |
Foamix Ltd. |
Pharmaceutical composition for topical application
|
DE10036871A1
(de)
*
|
2000-07-28 |
2002-02-14 |
Pharmasol Gmbh |
Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe
|
US8586094B2
(en)
|
2000-09-20 |
2013-11-19 |
Jagotec Ag |
Coated tablets
|
US20030072807A1
(en)
*
|
2000-12-22 |
2003-04-17 |
Wong Joseph Chung-Tak |
Solid particulate antifungal compositions for pharmaceutical use
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
US8067032B2
(en)
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
US20030096013A1
(en)
*
|
2000-12-22 |
2003-05-22 |
Jane Werling |
Preparation of submicron sized particles with polymorph control
|
US6977085B2
(en)
*
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
US20040022862A1
(en)
*
|
2000-12-22 |
2004-02-05 |
Kipp James E. |
Method for preparing small particles
|
US7193084B2
(en)
*
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
US6951656B2
(en)
*
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US6884436B2
(en)
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
US20050048126A1
(en)
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
US6607784B2
(en)
*
|
2000-12-22 |
2003-08-19 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US20040126900A1
(en)
*
|
2001-04-13 |
2004-07-01 |
Barry Stephen E |
High affinity peptide- containing nanoparticles
|
EP2545937A1
(en)
*
|
2001-06-05 |
2013-01-16 |
The Regents Of The University Of Michigan |
Nanoemulsion vaccines
|
US6676958B2
(en)
*
|
2001-06-19 |
2004-01-13 |
Advanced Bioadjuvants, Llc |
Adjuvant composition for mucosal and injection delivered vaccines
|
CN102294023A
(zh)
*
|
2001-07-26 |
2011-12-28 |
奥塔戈创新公司 |
抗原组合物
|
WO2003013513A1
(en)
*
|
2001-08-03 |
2003-02-20 |
Takeda Chemical Industries, Ltd. |
Stable emulsion composition
|
US7125568B2
(en)
*
|
2001-08-23 |
2006-10-24 |
Sung Michael T |
Lipophilic drug compositions
|
CA2461349C
(en)
|
2001-09-26 |
2011-11-29 |
Baxter International Inc. |
Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
|
US20060003012A9
(en)
*
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
IL145926A0
(en)
*
|
2001-10-15 |
2002-07-25 |
Mor Research Applic Ltd |
Peptide epitopes of mimotopes useful in immunomodulation
|
US7112340B2
(en)
*
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
AU2002353118A1
(en)
*
|
2001-12-11 |
2003-07-24 |
Dor Biopharma, Inc. |
Lipid particles and suspensions and uses thereof
|
US7763663B2
(en)
*
|
2001-12-19 |
2010-07-27 |
University Of Massachusetts |
Polysaccharide-containing block copolymer particles and uses thereof
|
JP4549625B2
(ja)
*
|
2002-01-05 |
2010-09-22 |
株式會社アモーレパシフィック |
人参サポニン代謝産物を有効成分とする微細乳化粒子及びその製造方法、並びにこれを含有する皮膚老化防止用の化粧料組成物
|
KR20030065831A
(ko)
*
|
2002-02-01 |
2003-08-09 |
주식회사 태평양 |
사이클로스포린을 함유한 지속 방출형 약학적 조성물
|
US6899890B2
(en)
*
|
2002-03-20 |
2005-05-31 |
Kv Pharmaceutical Company |
Bioadhesive drug delivery system
|
US6824763B2
(en)
|
2002-05-30 |
2004-11-30 |
Kimberly-Clark Worldwide, Inc. |
Anti-fungal powder having enhanced excipient properties
|
US8435942B2
(en)
*
|
2002-05-31 |
2013-05-07 |
Transdermal Biotechnology, Inc. |
Methods for formulating stabilized insulin compositions
|
US20040018237A1
(en)
*
|
2002-05-31 |
2004-01-29 |
Perricone Nicholas V. |
Topical drug delivery using phosphatidylcholine
|
HUP0202032A2
(hu)
*
|
2002-06-19 |
2004-10-28 |
D. Endre Radics |
Nanoemulziós formulációban található bioaktív anyagok emberi szervezetbe való bevitele a szájüreg nyálkahártyáján keresztül, mechanikus pumpájú spray által.
|
AU2003257285A1
(en)
*
|
2002-07-25 |
2004-02-16 |
Micrologix Biotech Inc. |
Inhibitors of rna dependent rna polymerase and uses thereof
|
US20040213837A1
(en)
*
|
2002-08-05 |
2004-10-28 |
Sankaram Mantripragada |
Oil-core compositions for the sustained release of hydrophobic drugs
|
AU2003284304B8
(en)
*
|
2002-10-21 |
2009-08-06 |
Nagler, Richard |
Surface coating comprising bioactive compound
|
IL152486A0
(en)
|
2002-10-25 |
2003-05-29 |
Meir Eini |
Alcohol-free cosmetic and pharmaceutical foam carrier
|
US7700076B2
(en)
|
2002-10-25 |
2010-04-20 |
Foamix, Ltd. |
Penetrating pharmaceutical foam
|
US8119150B2
(en)
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Non-flammable insecticide composition and uses thereof
|
US8900554B2
(en)
|
2002-10-25 |
2014-12-02 |
Foamix Pharmaceuticals Ltd. |
Foamable composition and uses thereof
|
US7820145B2
(en)
|
2003-08-04 |
2010-10-26 |
Foamix Ltd. |
Oleaginous pharmaceutical and cosmetic foam
|
US20080138296A1
(en)
|
2002-10-25 |
2008-06-12 |
Foamix Ltd. |
Foam prepared from nanoemulsions and uses
|
US9668972B2
(en)
|
2002-10-25 |
2017-06-06 |
Foamix Pharmaceuticals Ltd. |
Nonsteroidal immunomodulating kit and composition and uses thereof
|
US9265725B2
(en)
|
2002-10-25 |
2016-02-23 |
Foamix Pharmaceuticals Ltd. |
Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
|
US8486376B2
(en)
|
2002-10-25 |
2013-07-16 |
Foamix Ltd. |
Moisturizing foam containing lanolin
|
US8119109B2
(en)
|
2002-10-25 |
2012-02-21 |
Foamix Ltd. |
Foamable compositions, kits and methods for hyperhidrosis
|
US7704518B2
(en)
|
2003-08-04 |
2010-04-27 |
Foamix, Ltd. |
Foamable vehicle and pharmaceutical compositions thereof
|
US10117812B2
(en)
|
2002-10-25 |
2018-11-06 |
Foamix Pharmaceuticals Ltd. |
Foamable composition combining a polar solvent and a hydrophobic carrier
|
EP1556009B2
(en)
|
2002-10-25 |
2021-07-21 |
Foamix Pharmaceuticals Ltd. |
Cosmetic and pharmaceutical foam
|
US9211259B2
(en)
|
2002-11-29 |
2015-12-15 |
Foamix Pharmaceuticals Ltd. |
Antibiotic kit and composition and uses thereof
|
ITMI20022323A1
(it)
*
|
2002-10-31 |
2004-05-01 |
Maria Rosa Gasco |
Composizioni farmaceutiche atte al trattamento di malattie oftalmiche.
|
US7255867B2
(en)
*
|
2002-11-15 |
2007-08-14 |
Id Biomedical Corporation Of Quebec |
Vaccine
|
ES2376875T3
(es)
|
2003-02-14 |
2012-03-20 |
Children's Hospital & Research Center At Oakland |
Vehículo de administración de fármacos lipofílicos y métodos de utilización del mismo
|
US7812120B2
(en)
*
|
2003-03-21 |
2010-10-12 |
Par Pharmaceutical, Inc. |
Nasal calcitonin formulations containing chlorobutanol
|
US7575739B2
(en)
|
2003-04-28 |
2009-08-18 |
Foamix Ltd. |
Foamable iodine composition
|
US20050208083A1
(en)
|
2003-06-04 |
2005-09-22 |
Nanobio Corporation |
Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
|
US7368537B2
(en)
*
|
2003-07-15 |
2008-05-06 |
Id Biomedical Corporation Of Quebec |
Subunit vaccine against respiratory syncytial virus infection
|
US8795693B2
(en)
|
2003-08-04 |
2014-08-05 |
Foamix Ltd. |
Compositions with modulating agents
|
US8486374B2
(en)
|
2003-08-04 |
2013-07-16 |
Foamix Ltd. |
Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
|
WO2005027964A1
(en)
*
|
2003-09-15 |
2005-03-31 |
Id Biomedical Corporation Of Quebec |
Measles subunit vaccine
|
WO2005030172A1
(en)
*
|
2003-09-24 |
2005-04-07 |
The Regents Of The University And Methods |
Antimicrobial nanoemulsion compositions and methods
|
NZ546379A
(en)
*
|
2003-10-31 |
2010-04-30 |
Teva Pharma |
Nanoparticles for drug delivery
|
JP2007520555A
(ja)
*
|
2004-02-05 |
2007-07-26 |
バクスター・インターナショナル・インコーポレイテッド |
自己安定化剤の使用により調製された分散剤
|
ES2387619T3
(es)
*
|
2004-04-19 |
2012-09-27 |
Centre National De La Recherche Scientifique (Cnrs) |
Suplementos de tensioactivos pulmonares
|
ITMI20041151A1
(it)
*
|
2004-06-09 |
2004-09-09 |
Maria Rosa Gasco |
Nanoparticelle lipidiche come agenti veicolanti per acidi nucleici procedimento per la loro preparazione e loro uso
|
US7348802B2
(en)
*
|
2004-06-15 |
2008-03-25 |
Stmicroelectronics Pvt. Ltd. |
Differential receiver
|
EP1761276B1
(en)
|
2004-06-25 |
2013-07-24 |
ID Biomedical Corporation of Quebec |
Compositions and methods for treating neurological disorders
|
JP2008505114A
(ja)
*
|
2004-06-30 |
2008-02-21 |
アイディー バイオメディカル コーポレイション オブ ケベック |
コロナウイルス感染を処置するためのワクチン組成物
|
US7871632B2
(en)
|
2004-07-12 |
2011-01-18 |
Adventrx Pharmaceuticals, Inc. |
Compositions for delivering highly water soluble drugs
|
US20060057216A1
(en)
*
|
2004-09-15 |
2006-03-16 |
Salamone Joseph C |
Low-obscuration image transmitting particulate ocular therapeutic formulations
|
EP1674085A1
(en)
*
|
2004-12-22 |
2006-06-28 |
Universite Libre De Bruxelles |
Solid lipidic particles as pharmaceutically acceptable fillers or carriers for inhalation
|
EP1861067A2
(en)
*
|
2005-03-09 |
2007-12-05 |
Combe Incorporated |
Stable mixed emulsions comprising semisolid dispersions of at least two discrete and distinctly different particle size ranges
|
FR2885538B1
(fr)
*
|
2005-05-16 |
2007-08-10 |
Univ Claude Bernard Lyon |
Nouveau procede de preparation de particules lipidiques solides, mettant en oeuvre un reacteur membranaire
|
FR2887457B1
(fr)
*
|
2005-06-23 |
2007-10-05 |
Fond Bettencourt Schueller |
Vaccination par ciblage transcutane
|
KR101430767B1
(ko)
|
2005-07-18 |
2014-08-19 |
유니버시티 오브 메사츄세츠 로웰 |
나노에멀젼 조성물 및 이의 제조 및 사용 방법
|
US20070065390A1
(en)
*
|
2005-09-19 |
2007-03-22 |
Eric Spengler |
Stable emulsion systems with high salt tolerance
|
SI1933809T1
(sl)
*
|
2005-10-11 |
2012-08-31 |
Yissum Res Dev Co |
Sestavki za mazalno dajanje
|
US7638142B2
(en)
*
|
2005-10-12 |
2009-12-29 |
Vitamin Science, Inc. |
Therapeutic composition for the treatment of dry eye syndrome
|
EP1945340B1
(de)
*
|
2005-11-10 |
2016-11-02 |
Karl-Heinz Parras |
Langzeitstabile dispersion und verfahren zur herstellung der dispersion
|
KR20200052989A
(ko)
|
2005-12-01 |
2020-05-15 |
유니버시티 오브 메사츄세츠 로웰 |
보툴리눔 나노에멀젼
|
US9486408B2
(en)
|
2005-12-01 |
2016-11-08 |
University Of Massachusetts Lowell |
Botulinum nanoemulsions
|
KR100792557B1
(ko)
*
|
2006-04-05 |
2008-01-09 |
한남대학교 산학협력단 |
나노 캡슐화를 이용하여 제조된 지질 핵 및 고분자 쉘구조를 갖는 단백질 약물 전달용 나노 미립구
|
US10138279B2
(en)
|
2006-04-13 |
2018-11-27 |
Regents Of The University Of Michigan |
Compositions and methods for Bacillus anthracis vaccination
|
US20080038295A1
(en)
*
|
2006-04-13 |
2008-02-14 |
Regents Of The University Of Michigan |
Compositions and methods for orthopox virus vaccination
|
US9839685B2
(en)
*
|
2006-04-13 |
2017-12-12 |
The Regents Of The University Of Michigan |
Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen
|
US20070243137A1
(en)
*
|
2006-04-18 |
2007-10-18 |
Nanoprobes, Inc. |
Cell and sub-cell methods for imaging and therapy
|
AU2007295178B2
(en)
*
|
2006-09-15 |
2013-04-18 |
Echo Pharmaceuticals B.V. |
Granulate containing a pharmaceutically active substance and anemulsifier and method for its manufacture
|
US20080260655A1
(en)
|
2006-11-14 |
2008-10-23 |
Dov Tamarkin |
Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
|
EP2494958A1
(en)
|
2006-12-01 |
2012-09-05 |
Anterios, Inc. |
Amphiphilic Entity Nanoparticles
|
AU2007353340A1
(en)
|
2006-12-01 |
2008-11-20 |
Anterios, Inc. |
Peptide nanoparticles and uses therefor
|
BRPI0807095A2
(pt)
*
|
2007-02-07 |
2014-04-22 |
Sigma Tau Ind Farmaceuti |
Antígenos recombinantes de citomegalovírus humano (hcmv)
|
AU2008222822A1
(en)
|
2007-03-05 |
2008-09-12 |
Washington University |
Nanoparticle delivery systems for membrane-integrating peptides
|
ES2542058T3
(es)
|
2007-03-30 |
2015-07-30 |
Particle Sciences, Inc. |
Formulaciones en forma de partículas y usos de las mismas
|
US8747872B2
(en)
|
2007-05-02 |
2014-06-10 |
The Regents Of The University Of Michigan |
Nanoemulsion therapeutic compositions and methods of using the same
|
WO2008135855A2
(en)
|
2007-05-03 |
2008-11-13 |
Pfizer Products Inc. |
Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
|
WO2008135828A2
(en)
|
2007-05-03 |
2008-11-13 |
Pfizer Products Inc. |
Nanoparticles comprising a drug, ethylcellulose, and a bile salt
|
US8722736B2
(en)
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
US8426467B2
(en)
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
US20080292663A1
(en)
*
|
2007-05-22 |
2008-11-27 |
Gerber Jay D |
Adjuvant compositions and methods for delivering vaccines
|
EP2162117B1
(en)
|
2007-05-31 |
2018-02-21 |
Anterios, Inc. |
Nucleic acid nanoparticles and uses therefor
|
US8974827B2
(en)
|
2007-06-04 |
2015-03-10 |
Bend Research, Inc. |
Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
|
WO2008149230A2
(en)
|
2007-06-04 |
2008-12-11 |
Pfizer Products Inc. |
Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
|
US8636982B2
(en)
|
2007-08-07 |
2014-01-28 |
Foamix Ltd. |
Wax foamable vehicle and pharmaceutical compositions thereof
|
WO2009042114A2
(en)
|
2007-09-21 |
2009-04-02 |
The Johns Hopkins University |
Phenazine derivatives and uses thereof
|
WO2009069006A2
(en)
|
2007-11-30 |
2009-06-04 |
Foamix Ltd. |
Foam containing benzoyl peroxide
|
EP2240162A4
(en)
|
2007-12-06 |
2013-10-09 |
Bend Res Inc |
NANOTE PARTICLES WITH A NON-IONIZABLE POLYMER AND AN AMIN-FUNCTIONALIZED METHACRYLATE COPOLYMER
|
WO2009073215A1
(en)
|
2007-12-06 |
2009-06-11 |
Bend Research, Inc. |
Pharmaceutical compositions comprising nanoparticles and a resuspending material
|
US8518376B2
(en)
|
2007-12-07 |
2013-08-27 |
Foamix Ltd. |
Oil-based foamable carriers and formulations
|
WO2009072007A2
(en)
|
2007-12-07 |
2009-06-11 |
Foamix Ltd. |
Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
|
US8063020B2
(en)
*
|
2007-12-22 |
2011-11-22 |
Simpkins Cuthbert O |
Resuscitation fluid
|
US20100196461A1
(en)
*
|
2009-01-30 |
2010-08-05 |
Simpkins Cuthbert O |
Resuscitation fluid
|
US8906855B2
(en)
|
2007-12-22 |
2014-12-09 |
Vivacelle Bio, Inc. |
Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
|
US8618056B2
(en)
|
2007-12-22 |
2013-12-31 |
Cuthbert O. Simpkins |
Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
|
AU2009205314A1
(en)
|
2008-01-14 |
2009-07-23 |
Foamix Ltd. |
Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
|
WO2009143175A2
(en)
*
|
2008-05-19 |
2009-11-26 |
Children's Medical Center Corporation |
Sensory-specific local anesthesia and prolonged duration local anesthesia
|
WO2009143174A2
(en)
*
|
2008-05-19 |
2009-11-26 |
Children's Medical Center Corporation |
Chemical permeation enhancers enhance nerve blockade by toxins
|
CA2725329C
(en)
|
2008-05-23 |
2013-10-01 |
The Regents Of The University Of Michigan |
Nanoemulsion vaccines
|
WO2009158678A1
(en)
|
2008-06-27 |
2009-12-30 |
Children's Hospital & Research Center At Oakland |
Lipophilic nucleic acid delivery vehicle and methods of use therefor
|
DE102008045152A1
(de)
*
|
2008-07-09 |
2010-01-14 |
Universität Duisburg-Essen |
Künstliche Sauerstoffträger und ihre Verwendung
|
US20100015240A1
(en)
*
|
2008-07-16 |
2010-01-21 |
Danielle Biggs |
Process for preparing microparticles containing bioactive peptides
|
WO2010036938A2
(en)
|
2008-09-26 |
2010-04-01 |
Nanobio Corporation |
Nanoemulsion therapeutic compositions and methods of using the same
|
WO2010042499A1
(en)
*
|
2008-10-06 |
2010-04-15 |
Banner Pharmacaps, Inc. |
Stable solutions of orlistat for pharmaceutical dosage forms
|
US9974844B2
(en)
|
2008-11-17 |
2018-05-22 |
The Regents Of The University Of Michigan |
Cancer vaccine compositions and methods of using the same
|
FR2939699B1
(fr)
|
2008-12-12 |
2011-05-06 |
Univ Angers |
Procede de preparation de nanoparticules lipidiques
|
US8957207B2
(en)
|
2009-03-24 |
2015-02-17 |
Proteus S.A. |
Methods for producing phycotoxins
|
US20100267842A1
(en)
*
|
2009-04-15 |
2010-10-21 |
Richard Kiral |
Emulsions of Perfluorocarbons
|
WO2010125470A2
(en)
|
2009-04-28 |
2010-11-04 |
Foamix Ltd. |
Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
|
US8668911B2
(en)
*
|
2009-05-14 |
2014-03-11 |
The Regents Of The University Of Michigan |
Streptococcus vaccine compositions and methods of using the same
|
CN101579291B
(zh)
*
|
2009-05-20 |
2011-06-15 |
清华大学 |
一种白藜芦醇磷脂复合物纳米乳液及其制备方法与应用
|
CN102596243B
(zh)
*
|
2009-06-16 |
2015-10-21 |
密执安大学评议会 |
纳米乳剂疫苗
|
CA2769625C
(en)
|
2009-07-29 |
2017-04-11 |
Foamix Ltd. |
Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
|
CA2769677A1
(en)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
|
WO2011017520A1
(en)
|
2009-08-05 |
2011-02-10 |
Wake Forest University Health Sciences |
Compositions and methods for inducing apoptosis in prostate cancer cells
|
AU2010302350B2
(en)
|
2009-10-02 |
2015-06-18 |
Journey Medical Corporation |
Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
|
US9849142B2
(en)
|
2009-10-02 |
2017-12-26 |
Foamix Pharmaceuticals Ltd. |
Methods for accelerated return of skin integrity and for the treatment of impetigo
|
US8174881B2
(en)
|
2009-11-24 |
2012-05-08 |
Micron Technology, Inc. |
Techniques for reducing disturbance in a semiconductor device
|
CN102933200B
(zh)
*
|
2009-12-18 |
2015-11-25 |
莱迪杜德制药公司 |
包含磷脂的单相凝胶组合物
|
FR2956320B1
(fr)
*
|
2010-02-17 |
2013-12-20 |
Commissariat Energie Atomique |
Nanoemulsion pour la delivrance d'au moins deux agents d'interet
|
US20110229516A1
(en)
*
|
2010-03-18 |
2011-09-22 |
The Clorox Company |
Adjuvant phase inversion concentrated nanoemulsion compositions
|
ES2548681T3
(es)
|
2010-03-24 |
2015-10-20 |
Medesis Pharma |
Sistema micelar inverso que comprende iones metálicos y uso del mismo
|
AU2011230619C1
(en)
|
2010-03-25 |
2016-06-23 |
Oregon Health & Science University |
CMV glycoproteins and recombinant vectors
|
TWI540319B
(zh)
|
2010-03-29 |
2016-07-01 |
中央研究院 |
以細胞質譜分析定量細胞所攝入之奈米/微米粒子
|
CN102232932B
(zh)
*
|
2010-04-27 |
2013-06-05 |
重庆莱美药业股份有限公司 |
果胶-阿霉素轭合物的冻干制剂及制备方法
|
US10758630B2
(en)
|
2010-08-13 |
2020-09-01 |
The Johns Hopkins University |
Topical compositions and methods of detection and treatment
|
US8658676B2
(en)
*
|
2010-10-12 |
2014-02-25 |
The Medicines Company |
Clevidipine emulsion formulations containing antimicrobial agents
|
WO2012094541A2
(en)
*
|
2011-01-05 |
2012-07-12 |
The Regents Of The University Of California |
Acoustically responsive particles with decreased cavitation threshold
|
EP2685962A1
(en)
|
2011-03-17 |
2014-01-22 |
Transdermal Biotechnology, Inc. |
Topical nitric oxide systems and methods of use thereof
|
EP2691530B1
(en)
|
2011-06-10 |
2018-03-07 |
Oregon Health & Science University |
Cmv glycoproteins and recombinant vectors
|
CN103857440B
(zh)
*
|
2011-06-22 |
2018-09-25 |
维奥姆生物科学有限公司 |
基于缀合物的抗真菌和抗细菌前药
|
EP2568289A3
(en)
|
2011-09-12 |
2013-04-03 |
International AIDS Vaccine Initiative |
Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
|
KR101803902B1
(ko)
*
|
2011-09-16 |
2017-12-04 |
(주)아모레퍼시픽 |
세라마이드를 포함하는 피부 외용제 조성물
|
WO2013040556A1
(en)
*
|
2011-09-16 |
2013-03-21 |
Nanocare Technologies, Inc. |
Compositions of jasmonate compounds and methods of use
|
EP2586461A1
(en)
|
2011-10-27 |
2013-05-01 |
Christopher L. Parks |
Viral particles derived from an enveloped virus
|
US20130142878A1
(en)
*
|
2011-12-01 |
2013-06-06 |
Flow Pharma, Inc. |
Peptide particle formulation
|
CA3170184A1
(en)
|
2012-03-12 |
2013-09-19 |
Advanced Bioadjuvants, Llc |
Adjuvant and vaccine compositions
|
TWI483747B
(zh)
*
|
2012-05-29 |
2015-05-11 |
Univ Nat Chiao Tung |
口服式藥物載體及其製備方法
|
ES2631608T3
(es)
|
2012-06-27 |
2017-09-01 |
International Aids Vaccine Initiative |
Variante de la glicoproteína Env del VIH-1
|
US8871254B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
|
US8871257B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
|
US8871255B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Treatment of skin and soft tissue infection with nitric oxide
|
US8871256B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Methods and systems for treatment of inflammatory diseases with nitric oxide
|
US8871259B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Techniques and systems for treatment of neuropathic pain and other indications
|
US8871262B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Compositions and methods for treatment of osteoporosis and other indications
|
US8871260B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Methods and compositions for muscular and neuromuscular diseases
|
US8871261B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Cancer treatments and compositions for use thereof
|
US8871258B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Treatment and prevention of learning and memory disorders
|
US20140234433A1
(en)
*
|
2013-02-15 |
2014-08-21 |
Nicholas V. Perricone |
Topical Composition for Stimulating Epidermis and Dermis Layers of the Skin
|
EP2958551B1
(en)
|
2013-02-25 |
2020-08-05 |
Particle Sciences, Inc. |
Particle formulations for delivery of tlr agonists and antigens
|
US9314422B2
(en)
|
2013-03-13 |
2016-04-19 |
Transdermal Biotechnology, Inc. |
Peptide systems and methods for metabolic conditions
|
US9320706B2
(en)
|
2013-03-13 |
2016-04-26 |
Transdermal Biotechnology, Inc. |
Immune modulation using peptides and other compositions
|
US9393264B2
(en)
|
2013-03-13 |
2016-07-19 |
Transdermal Biotechnology, Inc. |
Immune modulation using peptides and other compositions
|
US9393265B2
(en)
|
2013-03-13 |
2016-07-19 |
Transdermal Biotechnology, Inc. |
Wound healing using topical systems and methods
|
US20140271731A1
(en)
|
2013-03-13 |
2014-09-18 |
Transdermal Biotechnology, Inc. |
Cardiovascular disease treatment and prevention
|
US9339457B2
(en)
|
2013-03-13 |
2016-05-17 |
Transdermal Biotechnology, Inc. |
Cardiovascular disease treatment and prevention
|
US20140271937A1
(en)
|
2013-03-13 |
2014-09-18 |
Transdermal Biotechnology, Inc. |
Brain and neural treatments comprising peptides and other compositions
|
US9849160B2
(en)
|
2013-03-13 |
2017-12-26 |
Transdermal Biotechnology, Inc. |
Methods and systems for treating or preventing cancer
|
US9295637B2
(en)
|
2013-03-13 |
2016-03-29 |
Transdermal Biotechnology, Inc. |
Compositions and methods for affecting mood states
|
US20140271938A1
(en)
|
2013-03-13 |
2014-09-18 |
Transdermal Biotechnology, Inc. |
Systems and methods for delivery of peptides
|
US9314417B2
(en)
|
2013-03-13 |
2016-04-19 |
Transdermal Biotechnology, Inc. |
Treatment of skin, including aging skin, to improve appearance
|
US9724419B2
(en)
|
2013-03-13 |
2017-08-08 |
Transdermal Biotechnology, Inc. |
Peptide systems and methods for metabolic conditions
|
US9314433B2
(en)
|
2013-03-13 |
2016-04-19 |
Transdermal Biotechnology, Inc. |
Methods and systems for treating or preventing cancer
|
US9314423B2
(en)
|
2013-03-13 |
2016-04-19 |
Transdermal Biotechnology, Inc. |
Hair treatment systems and methods using peptides and other compositions
|
US9241899B2
(en)
|
2013-03-13 |
2016-01-26 |
Transdermal Biotechnology, Inc. |
Topical systems and methods for treating sexual dysfunction
|
US9295636B2
(en)
|
2013-03-13 |
2016-03-29 |
Transdermal Biotechnology, Inc. |
Wound healing using topical systems and methods
|
US9387159B2
(en)
|
2013-03-13 |
2016-07-12 |
Transdermal Biotechnology, Inc. |
Treatment of skin, including aging skin, to improve appearance
|
US9687520B2
(en)
|
2013-03-13 |
2017-06-27 |
Transdermal Biotechnology, Inc. |
Memory or learning improvement using peptide and other compositions
|
US9750787B2
(en)
|
2013-03-13 |
2017-09-05 |
Transdermal Biotechnology, Inc. |
Memory or learning improvement using peptide and other compositions
|
US9295647B2
(en)
|
2013-03-13 |
2016-03-29 |
Transdermal Biotechnology, Inc. |
Systems and methods for delivery of peptides
|
US9320758B2
(en)
|
2013-03-13 |
2016-04-26 |
Transdermal Biotechnology, Inc. |
Brain and neural treatments comprising peptides and other compositions
|
KR20220132666A
(ko)
|
2013-03-15 |
2022-09-30 |
더 칠드런스 메디칼 센터 코포레이션 |
지속성 국소 마취용 네오삭시톡신 조합 제형
|
FR3008900B1
(fr)
|
2013-07-25 |
2018-03-30 |
Centre Nat Rech Scient |
Nanoparticules lipidiques multicompartimentees
|
US20150065381A1
(en)
|
2013-09-05 |
2015-03-05 |
International Aids Vaccine Initiative |
Methods of identifying novel hiv-1 immunogens
|
US10058604B2
(en)
|
2013-10-07 |
2018-08-28 |
International Aids Vaccine Initiative |
Soluble HIV-1 envelope glycoprotein trimers
|
CA2926797A1
(en)
|
2013-10-14 |
2015-04-23 |
Nanosphere Health Sciences, Llc |
Nanoparticle compositions and methods as carriers of nutraceutical factors across cell membranes and biological barriers
|
CN105848479B
(zh)
|
2013-10-25 |
2018-07-13 |
英斯梅德股份有限公司 |
前列环素化合物、其组合物及使用方法
|
CN106163551A
(zh)
*
|
2013-12-31 |
2016-11-23 |
传染性疾病研究院 |
单瓶疫苗制剂
|
US9895311B2
(en)
*
|
2014-09-25 |
2018-02-20 |
Pharmiva Ab |
Foam-forming compositions and methods for delivering an active to a body cavity
|
CA2967385C
(en)
|
2014-11-18 |
2023-05-16 |
Insmed Incorporated |
Methods of manufacturing treprostinil and treprostinil derivative prodrugs
|
US20160151285A1
(en)
*
|
2014-11-28 |
2016-06-02 |
University Of Malaya |
Method to produce slow release delivery carrier lipid nanoparticles of different log p value
|
CA2970917C
(en)
|
2014-12-15 |
2019-09-17 |
Nanosphere Health Sciences, Llc |
Methods of treating inflammatory disorders and global inflammation with compositions comprising phospholipid nanoparticle encapsulations of nsaids
|
KR20170125811A
(ko)
|
2014-12-31 |
2017-11-15 |
나노케어 테크놀로지스 인코퍼레이티드 |
자스모네이트 유도체 및 그 조성물
|
US20180000727A1
(en)
*
|
2015-01-21 |
2018-01-04 |
Michael Willinsky |
Composition and methods to improve stability, dosing, pharmacodynamics and product shelf life of endocannabinoids, phytocannabinoids and synthetic cannabinoids delivered by nasal inhaer
|
WO2016144376A1
(en)
*
|
2015-03-10 |
2016-09-15 |
Nanosphere Health Sciences, Llc |
Lipid nanoparticle compositions and methods as carriers of cannabinoids in standardized precision-metered dosage forms
|
EP3069730A3
(en)
|
2015-03-20 |
2017-03-15 |
International Aids Vaccine Initiative |
Soluble hiv-1 envelope glycoprotein trimers
|
US9931394B2
(en)
|
2015-03-23 |
2018-04-03 |
International Aids Vaccine Initiative |
Soluble HIV-1 envelope glycoprotein trimers
|
US20160346219A1
(en)
|
2015-06-01 |
2016-12-01 |
Autotelic Llc |
Phospholipid-coated therapeutic agent nanoparticles and related methods
|
EA036155B1
(ru)
*
|
2015-10-16 |
2020-10-06 |
Маринус Фармасьютикалс, Инк. |
Инъекционные составы нейростероида, содержащие наночастицы
|
CA3027368A1
(en)
|
2016-06-13 |
2017-12-21 |
Ascendia Pharmaceuticals, Llc |
Parenteral sustained-release delivery of carvedilol disperse systems
|
US10398641B2
(en)
|
2016-09-08 |
2019-09-03 |
Foamix Pharmaceuticals Ltd. |
Compositions and methods for treating rosacea and acne
|
WO2018093465A1
(en)
|
2016-11-21 |
2018-05-24 |
Eirion Therapeutics, Inc. |
Transdermal delivery of large agents
|
EP3582755A4
(en)
*
|
2017-02-15 |
2020-12-23 |
Molecular Infusions, LLC |
FORMULATIONS
|
PT3628002T
(pt)
|
2017-05-23 |
2023-05-10 |
Pharmiva Ab |
Composições de formação de espuma para entregar um activo a uma cavidade corporal
|
TWI719263B
(zh)
*
|
2017-10-27 |
2021-02-21 |
財團法人國家衛生研究院 |
用於鼻黏膜之奈米級乳液免疫載劑及其製備方法
|
KR102052912B1
(ko)
*
|
2018-03-30 |
2019-12-06 |
중앙대학교 산학협력단 |
산소를 함유하는 나노 버블의 제조 방법, 나노 버블 및 이를 포함하는 약물 전달체
|
BR112021001323A2
(pt)
*
|
2018-07-18 |
2021-04-20 |
Glatt Gmbh |
formulações de liberação prolongada de canabinoides
|
MX2021006912A
(es)
*
|
2018-12-11 |
2021-08-24 |
Disruption Labs Inc |
Composiciones para la administracion de agentes terapeuticos y metodos de uso y fabricacion de las mismas.
|
EP3937912A4
(en)
*
|
2019-03-13 |
2022-12-21 |
Ulagaraj Selvaraj |
STABILIZED SOLID NANOPARTICLE FORMULATIONS OF CANNABINOIDS AND CANNABINOID ANALOGS WITH REDUCED OSTWALD RIPENING FOR ORAL, INHALATION, NASAL AND PARENTERAL DRUG DELIVERY
|
TR201905678A2
(tr)
*
|
2019-04-16 |
2020-11-23 |
Istanbul Medipol Ueniversitesi |
Kurkumi̇n ve pi̇peri̇n doğal bi̇leşenleri̇ni̇ i̇hti̇va eden kati li̇pi̇t emulsi̇yonlarinin tedavi̇ amaçli uygulamalari
|
CN114072136A
(zh)
|
2019-04-29 |
2022-02-18 |
英斯梅德股份有限公司 |
曲前列素前药的干粉组合物及其使用方法
|
US20200352191A1
(en)
*
|
2019-05-06 |
2020-11-12 |
Karl Lonsbery |
Edible formulations and uses thereof
|
AU2020417820A1
(en)
*
|
2020-01-02 |
2022-08-18 |
Spoke Sciences, Inc. |
Systems and methods for generating homogenous mixtures of brewed beverages and active ingredients
|
US20220031625A1
(en)
*
|
2020-07-31 |
2022-02-03 |
Altaire Pharmaceuticals, Inc. |
Ophthalmic compositions for delivering meibum-like materials
|
US11058637B1
(en)
*
|
2020-11-25 |
2021-07-13 |
King Abdulaziz University |
Surface-modified emulsomes for intranasal delivery of drugs
|
WO2023108513A1
(zh)
*
|
2021-12-16 |
2023-06-22 |
威海天原生物科技有限公司 |
植物油制剂及其制备方法
|